David Muller

David Muller is a Senior Lecturer in Cancer Epidemiology and Biostatistics at Imperial College London's School of Public Health, part of the Faculty of Medicine. His research focuses on oncology, epidemiology, biostatistics, and public health, with an emphasis on cancer risk prediction, proteomic biomarkers, and disease comorbidity. He is affiliated with Imperial College London and contributes to large-scale cohort studies like EPIC and the Lung Cancer Cohort Consortium (LC3).

His research interests include the development of risk prediction models for cancers such as breast, prostate, and lung, as well as the role of adiposity, proteomics, and environmental factors in cancer etiology. Recent work explores multimorbidity of cancer and cardiometabolic diseases, spatial cancer mortality trends in England, and the epidemiology of headaches linked to mobile phone use.

Publications highlight his expertise in biomarker discovery (e.g., proteomic profiling for cancer detection), the impact of body composition on cancer prognosis, and methodological advancements in cohort studies. His work integrates statistical methodologies to address clinical and public health challenges in oncology.

No scientific awards or grants are explicitly mentioned in the provided text. He has no listed advisees or students, though collaborations with international cohorts suggest mentorship roles in large-scale research initiatives.